Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$44.03 USD
-0.08 (-0.18%)
Updated May 17, 2024 03:59 PM ET
After-Market: $44.04 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 381 - 400 ( 438 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
New Products Did Well, Revenue Declines Easing
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of January 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Third Quarter Results Depressed by Loss of Plavix Sales
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
HCV Update: Vertex Reports Impressive Phase 1 Nuc Data; Seeking DAA(s) for Combination in Phase 2; Read-through for ACHN and IDIX
Provider: WEDBUSH SECURITIES INC.
Analyst: FELT A
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Plavix Patent Expiration Impacted Second Quarter Results
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company to Acquire Amylin Pharmaceuticals, Expand Partnership with AstraZeneca
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company to Acquire Amylin Pharmaceuticals, Expand Partnership with AstraZeneca
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K